BioMimetic Investor Says $380M Buyout Deal Doesn't Cut It

Law360, Wilmington (November 26, 2012, 9:43 PM EST) -- A BioMimetic Therapeutics Inc. investor launched a putative class action Wednesday protesting the orthopedic therapy company's planned $380 million buyout by Wright Medical Technology Inc., claiming the deal greatly undervalues a company on the verge of a major breakthrough.

Filed by shareholder Menachem Maiman in Delaware court, the complaint alleges that BioMimetic's board breached its fiduciary duty by attempting to sell the orthopedic and sports-medicine therapy company “by means of an unfair process and for an unfair price.”

The proposed deal would shortchange shareholders because it...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.